Tech Company Financing Transactions
SoniVie Funding Round
SoniVie, based in St Paul, raised $60 million in funding from Andera Partners, Omega Funds and Supernova Invest.
Transaction Overview
Company Name
Announced On
1/9/2023
Transaction Type
Venture Equity
Amount
$60,000,000
Round
Series C
Investors
Proceeds Purpose
The company intends to use the funds to support its clinical and regulatory path towards pre-market approval of its TIVUS technology for the treatment of hypertension.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
758 Stillwater Rd,
St Paul, MN 55115
USA
St Paul, MN 55115
USA
Phone
Undisclosed
Website
Email Address
Overview
Founded in 2014 on the achievements of the Therapeutic Intra-Vascular UltraSound-based technology (TIVUS) developed by Cardiosonic for Renal Artery Denervation, Sonivie further developed the technology for Pulmonary Hypertension.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Zvika Slovin
Chief Executive Officer
Tomaso Zambelli
Chief Medical Officer
Christian Spaulding
Browse more venture capital transactions:
Prev: 1/9/2023: XetHub venture capital transaction
Next: 1/10/2023: Paytient venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs